Cristal Therapeutics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Cristal Therapeutics General Information
Description
Developer of nanomedicine designed to improve targeted therapy for cancer and other diseases. The company utilizes a proprietary polymeric nanoparticle construct and copper-free click chemistry to deliver therapeutics to specific tissues, cells, and intracellular components, enabling oncologists and medical practitioners to enhance precision in cancer treatment and address a broader range of diseases with improved efficacy.
Contact Information
Website
www.cristaltherapeutics.comCorporate Office
- Oxfordlaan 55
- 6229 EV Maastricht
- Netherlands
Corporate Office
- Oxfordlaan 55
- 6229 EV Maastricht
- Netherlands
Cristal Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | 01-Jan-2026 | Completed | Generating Revenue | |||
| 8. Later Stage VC | Completed | Generating Revenue | ||||
| 7. Grant | 28-Nov-2017 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 19-Jan-2017 | Completed | Generating Revenue | |||
| 5. Grant | 20-Jun-2016 | Completed | Clinical Trials - Phase 1 | |||
| 4. Grant | 01-Jan-2015 | Completed | Clinical Trials - Phase 1 | |||
| 3. Early Stage VC | 15-Dec-2014 | Completed | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC | 01-Jul-2013 | Completed | Clinical Trials - Phase 1 | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Cristal Therapeutics Comparisons
Industry
Financing
Details
Cristal Therapeutics Competitors (94)
One of Cristal Therapeutics’s 94 competitors is Centrose, a Venture Capital-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Centrose | Venture Capital-Backed | Madison, WI | ||||
| Meditope Biosciences | Formerly VC-backed | Pasadena, CA | ||||
| Oxford Biotherapeutics | Private Equity-Backed | Oxford, United Kingdom | ||||
| AnTolRx | Formerly VC-backed | Cambridge, MA | ||||
| Alpha Tau Medical | Formerly VC-backed | Jerusalem, Israel |
Cristal Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Cristal Therapeutics Patents
Cristal Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4731621-A1 | Peptide coupling using thiocycloheptyne derivatives | Pending | 20-Jun-2023 | ||
| WO-2024263030-A1 | Peptide coupling using thiocycloheptyne derivatives | Inactive | 20-Jun-2023 | ||
| EP-3820858-A1 | Thiocycloheptyne derivatives and their use | Pending | 13-Jul-2018 | ||
| US-12054471-B2 | Thiocycloheptyne derivatives and their use | Active | 13-Jul-2018 | ||
| US-20210395216-A1 | Thiocycloheptyne derivatives and their use | Active | 13-Jul-2018 | C07D337/04 |
Cristal Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Cristal Therapeutics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aglaia Oncology Funds | Venture Capital | Minority | ||
| DPI Value Centre | Corporation | Minority | ||
| BVP (Brightlands Venture Partners) | Venture Capital | Minority | ||
| LifeSciences@Work | Accelerator/Incubator |
Cristal Therapeutics FAQs
-
When was Cristal Therapeutics founded?
Cristal Therapeutics was founded in 2011.
-
Where is Cristal Therapeutics headquartered?
Cristal Therapeutics is headquartered in Maastricht, Netherlands.
-
What is the size of Cristal Therapeutics?
Cristal Therapeutics has 4 total employees.
-
What industry is Cristal Therapeutics in?
Cristal Therapeutics’s primary industry is Drug Discovery.
-
Is Cristal Therapeutics a private or public company?
Cristal Therapeutics is a Private company.
-
What is Cristal Therapeutics’s current revenue?
The current revenue for Cristal Therapeutics is .
-
How much funding has Cristal Therapeutics raised over time?
Cristal Therapeutics has raised $20.9M.
-
Who are Cristal Therapeutics’s investors?
Aglaia Oncology Funds, DPI Value Centre, BVP (Brightlands Venture Partners), and LifeSciences@Work have invested in Cristal Therapeutics.
-
Who are Cristal Therapeutics’s competitors?
Centrose, Meditope Biosciences, Oxford Biotherapeutics, AnTolRx, and Alpha Tau Medical are some of the 94 competitors of Cristal Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
